Longevity
MOTS-c What the Research Actually Says: Evidence Review
MOTS-c has a more rigorous research foundation than most peptides marketed to consumers.
MOTS-c How It Works: Mechanism of Action Explained Simply
MOTS-c sits at an unusual intersection of cell biology.
MOTS-c Dosing Protocol: Cycling, Frequency & Best Practices
MOTS-c dosing in clinical practice is best understood as extrapolation.
MOTS-c Complete Guide: Benefits, Dosing, Side Effects & Research
Introduction MOTS-c is one of the more scientifically interesting peptides in the longevity space because, unlike most peptides marketed to consumers, it has a…
Melanotan II: The Tanning Peptide (Risks & Realities)
Introduction Melanotan II is a synthetic melanocortin receptor agonist developed in the 1980s at the University of Arizona as part of a research program…
LL-37: Can You Stack It with GLP-1 Medications?
No clinical trial has tested LL-37 combined with semaglutide, tirzepatide, or any other GLP-1 receptor agonist.
LL-37 How It Works: Mechanism of Action Explained Simply
LL-37 has more mechanism research behind it than most peptides marketed in wellness contexts.
LL-37 What the Research Actually Says: Evidence Review
LL-37 has one of the largest research literatures of any peptide marketed in wellness contexts.
LL-37 Dosing Protocol: Cycling, Frequency & Best Practices
LL-37 has no FDA-approved human dose for any indication.
